Back to top

Roth MKM Keeps Their Buy Rating on Equillium (EQ)

In a report released today, Adam Walsh from Roth MKM maintained a Buy rating on Equillium, with a price target of $12.00. Walsh covers the Healthca...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Equillium, Inc. (EQ)